Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGM:BWMN
NasdaqGM:BWMNConstruction

Bowman Consulting Group (BWMN) Margin Gains Test Lofty P/E Narrative After FY 2025 Earnings

Bowman Consulting Group (BWMN) has wrapped up FY 2025 with fourth quarter revenue of US$129.0 million and basic EPS of US$0.11, alongside trailing twelve month EPS of US$0.74 on revenue of US$490.0 million. The company has seen quarterly revenue move from US$113.2 million in Q4 2024 to US$129.0 million in Q4 2025, while basic EPS shifted from US$0.35 to US$0.11 over the same period, with trailing twelve month EPS rising from US$0.18 to US$0.74. With earnings growth over the last year...
NasdaqGS:KURA
NasdaqGS:KURABiotechs

Kura Oncology (KURA) Deep FY 2025 Loss Reinforces Bearish Profitability Concerns

Kura Oncology (KURA) closed out FY 2025 with Q4 revenue of US$17.3 million and a basic EPS loss of US$0.92, alongside a net loss of US$81.0 million, while on a trailing twelve month basis revenue totalled US$67.5 million and EPS stood at a loss of US$3.18. Over the past six reported quarters, the company has seen quarterly revenue range from US$0 to US$53.9 million and basic EPS move between a loss of US$0.22 and a loss of US$0.92, giving investors a clear view of how the top line and per...
LSE:BARC
LSE:BARCBanks

Assessing Barclays (LSE:BARC) Valuation After Recent Short Term Share Price Weakness

Barclays share performance and recent context Barclays (LSE:BARC) has drawn investor attention after a mixed run in its share performance, with the stock showing a negative move over the past month but a positive total return over the past year. For context, the shares show a 17% decline over the past month and a 4% decline over the past 3 months. The 1 year total return figure sits at 38%. That backdrop frames how some investors are thinking about the bank’s current valuation and its recent...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

EyePoint Therapeutics (EYPT) Reports US$67.6 Million Quarterly Loss Testing Bullish Growth Narratives

EyePoint Therapeutics (EYPT) closed FY 2025 with fourth quarter revenue of about US$0.6 million and a basic EPS loss of US$0.81, alongside a full year trailing twelve month basic EPS loss of US$3.17 and revenue of US$31.4 million. Over recent periods the company has seen quarterly revenue move from US$11.6 million in Q4 FY 2024 to US$24.5 million in Q1 FY 2025, then to US$5.3 million and US$1.0 million in Q2 and Q3 FY 2025, while basic EPS losses ranged between US$0.54 and US$0.85 per...
NasdaqGS:CTSH
NasdaqGS:CTSHIT

Did Cognizant’s New AI Partnerships and Leadership Moves Just Shift Cognizant Technology Solutions' (CTSH) Investment Narrative?

Cognizant Technology Solutions recently reshuffled its leadership in Asia Pacific & Japan, renewed a multi-million-dollar digital transformation partnership with Travel + Leisure Co., expanded its Google Cloud collaboration to scale agentic AI, and secured a multi-year AI-powered workplace modernization deal with a leading commercial vehicle manufacturer. Together, these moves highlight Cognizant’s push to embed AI and automation more deeply into large, long-term client relationships across...
NasdaqGM:BRLT
NasdaqGM:BRLTSpecialty Retail

Brilliant Earth Group (BRLT) EPS Loss Replaces Prior Profit And Tests Bullish Turnaround Narratives

Brilliant Earth Group (BRLT) has wrapped up FY 2025 with fourth quarter revenue of US$124.4 million and a basic EPS loss of US$0.19, alongside trailing twelve month revenue of US$437.5 million and a basic EPS loss of US$0.25. This sets a clear earnings reset for investors to assess. Over recent periods, the company has seen quarterly revenue move from US$119.5 million in Q4 2024 to US$124.4 million in Q4 2025. Basic EPS shifted from US$0.03 in Q4 2024 to a loss of US$0.19 in Q4 2025, and...
NYSE:PRM
NYSE:PRMChemicals

A Look At Perimeter Solutions (PRM) Valuation After Revenue Growth And A Swing To Net Loss

Perimeter Solutions (PRM) has drawn fresh attention after reporting fourth quarter and full year 2025 results, with higher sales alongside a swing from prior year profit to substantial net losses and wider losses per share. See our latest analysis for Perimeter Solutions. Those earnings arrived after a choppy stretch for the stock, with a 1 day share price return of 0.75% and 7 day return of 3.53% sitting against a 30 day decline of 8.60% and 90 day decline of 15.08%. At the same time, the 1...
TSE:7013
TSE:7013Machinery

Assessing IHI (TSE:7013) Valuation After Strong Multi‑Year Returns And Elevated P/E Multiple

IHI (TSE:7013) has drawn fresh attention after recent share price swings, with the stock showing mixed short term moves alongside longer term gains. That kind of pattern often prompts investors to reassess fundamentals. See our latest analysis for IHI. At the latest share price of ¥3,921.0, IHI has paired a softer 7 day share price return of 5.75% with a strong 90 day share price return of 29.88%, alongside a very large 5 year total shareholder return of more than 10x. This suggests momentum...
TSX:AW
TSX:AWHospitality

A And W Food Services Of Canada (TSX:AW) Margin Rebound Challenges Long Term Bearish Narrative

Latest results and how the story is shifting A & W Food Services of Canada (TSX:AW) closed FY 2025 with Q4 revenue of $93.0 million and basic EPS of $0.71, alongside trailing twelve month revenue of $294.1 million and EPS of $2.30 as the latest snapshot of its earnings power. The company has seen quarterly revenue move from $76.0 million in Q3 2024 to between $61.1 million and $93.0 million across FY 2025, while quarterly EPS ranged from $0.37 to $0.71 over the same period, against a prior...
TSX:TCS
TSX:TCSSoftware

Tecsys Q3 2026 Net Margin Rebound Tests Premium P/E Narrative

Tecsys (TSX:TCS) has put up another solid quarter, reporting Q3 2026 revenue of CA$48.5 million and basic EPS of CA$0.12, alongside trailing twelve month revenue of CA$189.7 million and EPS of about CA$0.40 that reflect the recent rebound in earnings. The company has seen revenue move from CA$45.2 million in Q3 2025 to CA$48.5 million in Q3 2026, while quarterly EPS has shifted from CA$0.08 to CA$0.12 over the same period. This sets up a story of improving profitability that now sits against...
NYSE:PPL
NYSE:PPLElectric Utilities

Did PPL’s (PPL) US$1 Billion Composite Units Deal and Dividend Hike Just Redefine Its Equity Story?

PPL Corporation has completed a past US$1.00 billion composite corporate units offering of 20,000,000 equity/debt units priced at US$50.00 each with a US$0.94 per-unit discount, alongside reporting higher fourth-quarter and full-year 2025 sales, net income, and earnings per share from continuing operations. The company also raised its quarterly dividend by 4.6% to US$0.2850 per share and issued 2026 earnings guidance above 2025 results, highlighting confidence in its updated investment plan...
NasdaqGM:AQST
NasdaqGM:AQSTPharmaceuticals

Aquestive Therapeutics (AQST) Q4 Loss Surge Tests Bullish Margin Expansion Narrative

Aquestive Therapeutics (AQST) just wrapped up FY 2025 with Q4 total revenue of US$13.0 million and a basic EPS loss of US$0.26, alongside a trailing twelve month EPS loss of US$0.78 on US$44.5 million of revenue. The company has seen quarterly revenue move from US$8.7 million and a basic EPS loss of US$0.24 in Q1 2025 to US$10.0 million with a US$0.14 EPS loss in Q2, US$12.8 million with a US$0.14 EPS loss in Q3, and then US$13.0 million with a US$0.26 EPS loss in Q4. This leaves investors...
NYSE:USB
NYSE:USBBanks

A Look At U.S. Bancorp’s (USB) Valuation As Optimism Builds Around Earnings And Rate Cut Tailwinds

Recent commentary around U.S. Bancorp (USB) has focused on its earnings outlook, valuation metrics, and consistent capital returns, as investors weigh these factors alongside expectations for lower Federal Reserve interest rates and potential support for regional bank profitability. See our latest analysis for U.S. Bancorp. The recent 7 day share price return of a 5.85% decline and 1 month share price return of an 8.14% decline, against a current share price of $53.91, suggest momentum has...
TSX:IPO
TSX:IPOOil and Gas

InPlay Oil (TSX:IPO) Returns To Q4 Profit And Tests Bullish Earnings Growth Narratives

InPlay Oil (TSX:IPO) closed FY 2025 with Q4 revenue of C$85.1 million and basic EPS of C$0.11, alongside net income of C$3.0 million, while the trailing twelve months show total revenue of C$266.0 million and a loss of C$7.8 million, or basic EPS of C$0.32. Over the past year, the company has seen quarterly revenue range from C$34.2 million to C$85.1 million and basic EPS move between a loss of C$0.19 and a profit of C$0.15. This frames a story in which headline growth expectations and a...
TSX:KITS
TSX:KITSSpecialty Retail

Kits Eyecare (TSX:KITS) Q4 Margin Compression Tests High EPS Growth Narratives

Latest FY 2025 Results Set Up a Margins Conversation for Kits Eyecare Kits Eyecare (TSX:KITS) has wrapped up FY 2025 with fourth quarter revenue of $53.9 million and basic EPS of $0.01, alongside trailing twelve month revenue of $202.5 million and basic EPS of $0.10 that frame the scale of the business for investors watching the latest print. The company has seen quarterly revenue move from $44.8 million in Q4 2024 to $53.9 million in Q4 2025, while basic EPS shifted from $0.09 in Q4 2024 to...
NYSE:RBC
NYSE:RBCMachinery

Is RBC Bearings (RBC) Pricing In Too Much Optimism After Strong Multi Year Share Gains

If you are wondering whether RBC Bearings is still reasonably priced after its strong run, this article will walk through what the current share price might be baking in. The stock is now at US$566.06, after a 1.8% decline over the last 7 days, a 9.7% gain over 30 days, 23.4% year to date, 62.3% over 1 year and 146.3% over 3 years, with a 191.0% return over 5 years. Recent coverage around RBC Bearings has focused on its position in precision bearings and related components for industrial and...
NasdaqGS:DXCM
NasdaqGS:DXCMMedical Equipment

Evaluating DexCom (DXCM) After Recent Share Price Weakness And Perceived 17.3% Undervaluation

DexCom’s recent stock performance in focus DexCom (DXCM) has drawn attention after recent share price moves, with the stock down about 3% over the past day and roughly 5% over the past week, prompting closer scrutiny from investors. See our latest analysis for DexCom. Looking beyond today’s move, DexCom’s 90 day share price return of 7.94% and year to date share price return of 6.24%, set against a 1 year total shareholder return of an 11.09% decline, suggests momentum has improved recently...
NasdaqGM:PMTS
NasdaqGM:PMTSTech

CPI Card Group (PMTS) Margin Compression To 2.8% Tests Bullish Growth Narratives

CPI Card Group's FY 2025 earnings snapshot CPI Card Group (PMTS) has wrapped up FY 2025 with fourth quarter total revenue of US$153.1 million and basic EPS of US$0.64, alongside net income of US$7.4 million that frames the latest read on profitability. Over recent periods, the company has seen quarterly revenue move from US$125.1 million and EPS of US$0.61 in Q4 2024 to US$153.1 million and EPS of US$0.64 in Q4 2025. The trailing twelve months show US$543.5 million of revenue and EPS of...
NYSE:CHPT
NYSE:CHPTElectrical

ChargePoint Holdings (CHPT) Quarterly Loss Of US$44 Million Tests Profitability Narratives

ChargePoint Holdings (CHPT) has wrapped up FY 2026 with fourth quarter revenue of US$109.3 million and a basic EPS loss of US$1.85, alongside a quarterly net loss of US$44.4 million. Over the past six quarters, the company has seen revenue move in a tight band from US$99.6 million in FY 2025 Q3 to US$109.3 million in FY 2026 Q4. Quarterly basic EPS losses ranged from US$1.85 to US$3.56, and quarterly net losses spanned US$44.4 million to US$77.6 million, highlighting a business still...
NasdaqGM:MDWD
NasdaqGM:MDWDPharmaceuticals

MediWound (MDWD) Heavy FY 2025 Losses Test High Growth And Premium P/S Narrative

MediWound (NasdaqGM:MDWD) has just posted its FY 2025 numbers with Q4 revenue of US$1.9 million and a basic EPS loss of US$0.56, alongside full year trailing twelve month revenue of US$17.0 million and a net loss of US$23.9 million. Over recent periods, the company has seen quarterly revenue range from US$3.96 million to US$5.71 million with EPS moving between a loss of US$0.07 and US$1.23 per share. This sets the stage for a story that hinges on how quickly revenue growth can offset ongoing...
NYSE:JBI
NYSE:JBIBuilding

Janus International Group (JBI) Margin Slippage Challenges Bullish Reset Narrative

Janus International Group (JBI) has wrapped up FY 2025 with fourth quarter revenue of US$226.3 million and basic EPS of US$0.05, while trailing twelve month revenue came in at US$884.2 million and TTM EPS at US$0.39. Over recent periods the company has seen quarterly revenue move between US$210.5 million and US$230.8 million, with basic EPS ranging from roughly US$0.00 to US$0.15. This sets the backdrop for investors to judge how consistent profitability really looks. With a net profit margin...
ENXTAM:CVC
ENXTAM:CVCCapital Markets

Has CVC Capital Partners (ENXTAM:CVC) Selloff Created A Potential Valuation Opportunity?

If you are wondering whether CVC Capital Partners is starting to look interesting at its current share price, the key question is how that price compares with what the business might be worth. The stock last closed at €12.01, with returns of a 2.6% decline over 7 days, a 12.5% decline over 30 days, a 14.4% decline year to date and a 35.8% decline over 1 year. These moves may have changed how some investors view its risk and return profile. Recent coverage has focused on CVC Capital Partners...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

Meta Expands AI Chip Partners As Valuation Appears Below Analyst Estimates

Meta Platforms (NasdaqGS:META) has entered a multi year partnership with AMD to equip its next generation AI data centers with custom AMD Instinct GPUs and EPYC CPUs. The company is also leasing Google's Tensor Processing Units, adding a second external AI chip source alongside its new AMD collaboration. The move expands Meta's supplier base beyond a single chip provider and supports its long term build out of AI infrastructure. For investors, this points to Meta leaning further into AI as...
NYSEAM:REPX
NYSEAM:REPXOil and Gas

Riley Exploration Permian (REPX) One Off Gain Lifts EPS And Tests Bullish Earnings Narrative

Riley Exploration Permian (REPX) closed out FY 2025 with Q4 revenue of US$97.3 million and basic EPS of US$4.04, alongside full year trailing twelve month revenue of US$392.0 million and basic EPS of US$7.61. Over the last few quarters the company has seen revenue move from US$102.7 million in Q4 2024 to US$102.5 million in Q1 2025, US$85.4 million in Q2 2025, US$106.9 million in Q3 2025 and then US$97.3 million in Q4 2025, with quarterly EPS ranging from US$0.52 to US$4.04 over the same...